Comparison

Pramipexole European Partner

Item no. TMO-T1476-200mg
Manufacturer TargetMol
CASRN 104632-26-0
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 1 g 1 mL 200 mg 20 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Kvernmo T, et al. Curr Top Med Chem. 2008;8(12):1049-67.
Smiles CCCN[C@H]1CCc2c(C1)sc(N)n2
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias SND 919
Shipping Condition Cool pack
Available
Manufacturer - Targets
Dopamine Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
211.33
Description
Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury.
Pathways
Neuroscience|||GPCR/G Protein
Bioactivity
Pramipexole is a medication indicated for treating Parkinson's disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist.
Receptor
D2L; D2L; D3; D4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close